Interleukin-5 (IL-5) has previously been isolated only as a product of T lymphocytes. We have found that EpsteinBarr virus transformed B lymphocytes produce large amounts of IL-5 activity in culture supernatants, inducing proliferation of murine BCL, cells, and supporting the selective growth of eosinophil colonies in semi-solid culture. Production of IL-5 messenger RNA by transformed B-cell lines was verified by Northern analysis using a 3.2-NTERLEUKIN-5 (IL-5) is a hematopoietic growth fac-I tor that was initially studied in murine systems, where it was found to induce proliferation and differentiation of eosinophil precursors and promote proliferation and antibody production by B cells.' The gene coding for IL-5 was isolated from a murine T-cell hybridoma, molecularly cloned, and used to locate and clone the human IL-5 gene from a T-cell leukemia
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The murine and human IL-5 genes have 77% homology: and recombinantly produced human IL-5 has been found to induce the growth of human eosinophil colonies,',* but has lacked stimulatory effects in established human B-cell functional assays. ' Infection of human B cells by the Epstein-Barr virus (EBV) results in a permanent state of activation, in which the B cell is induced to express a number of activation antigens and to secrete substances with apparent growth factor a~t i v i t y .~ It is thought that an autocrine mechanism fuels the perpetual proliferation of EBV-transformed B cells in vitro. 5 We have found that EBV transformation of human B cells consistently results in the induction of production and secretion of large amounts of IL-5. This phenomenon may have physiologic relevance, since it suggests a possible expanded role for the B cell in the promotion of eosinophilia during type 1 immune responses. In addition, these findings may serve as a focus for further investigation into possible activities of IL-5 on human B cells.
MATERIALS AND METHODS
Establishment of EBV-transformed B-cell lines. Peripheral blood was obtained after informed consent on several occasions from each of two subjects with known previous exposure to EBV. We had determined previously that spontaneous EBV-transformed B-cell lines would emerge from suspension cultures of peripheral blood mononuclear cells of these subjects.' The mononuclear fraction was isolated after centrifugation of the buffy layer over Ficoll-Hypaque, and the cells were resuspended at 4 x 105/mL in complete medium consisting of RPMI-1640 containing 7.5% fetal calf serum, 2 mmol/L 1-glutamine, 1 mmol/L sodium pyruvate, 5 x mol/L 2-mercaptoethanol, and 40 pg/mL gentamicin. Suspension cultures were maintained in 75-cm' tissue culture flasks and fed periodically by replacement of one third of the medium. Transformed B-cell1 lines were seen to emerge at about 6 weeks, after which time they rapidly became the only viable elements in the cultures. The identity of the emerging cells was confirmed by flow cytometric analysis for the B-cell specific antigens CD20 and CD19, and the EBV-induced antigen CD23. Presence of EBV in the cell lines was confirmed by immunofluorescent labeling with anti-EBNA (Chemicon International Inc, El Segundo, CA). All EBV-transformed cell lines studied for growth factor activity had been maintained continuously in culture for more than a year. The purity of the populations was verified by flow cytometric analysis demonstrating absence of cell types other than B cells. In some instances, immunoglobulin gene rearrangement studies were performed, documenting the presence after long-term culture of pure B-cell clones. Culture supernatants were tested in two assays standardly used to detect IL-5 activity: the induction of proliferation of the murine B-cell line BCL,,' and the support of selective growth of eosinophil colonies in semi-solid cultures of human bone marrow.8 These assays are quite specific for the detection of IL-5 activity, as no human growth factor other than IL-5 has been shown to stimulate BCL, cells, and other lymphokines capable of stimulating eosinophil colony growth, such as granulocyte-macrophage colony-stimulating factor and IL-3, also stimulate the growth of other hematopoietic lineages under the culture conditions used. ' BCL, cells, freshly obtained after in vivo passage: were used for all assays. BCL, cells, 1 x lo5, were cultured in 96-well flat-bottomed tissue culture plates in either 0.2 mL complete medium alone or with the addition of 25% vol/vol medium conditioned by EBV-transformed B-cell lines. Quadruplicate cultures were incubated for 48 hours at 37OC before being labeled with 0.5 pCi 'H-thymidine for an additional 6 hours. The cultures were harvested onto glass fiber filters and the relative amount of radiolabel incorporation was determined by liquid scintillation counting. IL-5 activity present in B-cell supernatants was quantified by comparison to a reference curve constructed by culturing BCL, cells as above in varying concentrations of recombinant human IL-5 (generously provided by Steven Clark, Genetics Institute, Cambridge, MA).
Bone marrow from four normal volunteers was aspirated into heparinized syringes. The mononuclear cell fraction was cultured using standard methodology' in Iscove's Modified Dulbecco's medium with 0.8% methylcellulose (final concentration), containing 20% heat-inactivated fetal calf serum, 5 x IO-' mol/L 2-mercaptoethanol, and 2 mmol/L 1-glutamine. Colonies were scored on day 14 and were identified by characteristic morphology by inverted microscopy, with confirma- For Northern analysis for IL-5 messenger RNA (mRNA) expression by B-cell lines. Northern analysis was performed using standard methodology." Cells were lysed in 4 mol/L guanidinium solution and the lysate was ultracentrifuged through 5.5 mol/L cesium chloride and 0.1 mol/L EDTA for 18 hours. The RNA pellet was resuspended in 10 mmol/L Tris.Cl (pH 7.4), 5 mmol/L EDTA, and 1 % sodium dodecyl sulfate, ethanol-precipitated, and dissolved in diethylpyrocarbonate-treated water. Total cellular RNA (15 pg/ lane) was electrophoresed through a 1.3% denaturing agarose gel. Visualization of the 28s and 18s ribosomal RNA bands by ethidium bromide staining was used to ascertain that similar amounts of RNA were loaded in each lane before blotting to a nylon transfer membrane (Nytran, Schleicher & Schuell, Keene, NH). A 3.2-kilobase (kb) cloned DNA fragment containing the full-length human IL-5 gene" (generously provided by Steven Clark) was )*P-labeled by the random oligonucleotide primer method,'* and hybridized with the blot. The blot was then washed to greater than 90% stringency and autoradiographed at -7OOC using an intensifying screen.
Separation by polyacrylamide gel electrophoresis was performed using the PhastSystem (Pharmacia, Inc, Piscataway, NJ), with an 8% to 25% gradient, followed by diffusion blotting at 7OoC of separated proteins to nitrocellulose. The filter was blocked in phosphate-buffered saline containing 20% fetal calf serum. The primary antibody was the rat monoclonal anti-IL-5, TRFK-5') (gift of Donna Rennick, DNAX, Palo Alto, CA). As this antibody is known to react preferentially with dimeric IL-5 (personal communication, Dr Michael Grace, Schering Corp, November 1989), electophoresis conditions were nonreducing. The secondary antibody was a goat anti-rat immunoglobulin (Ig) G alkaline phosphatase conjugate (BRL, Inc, Gaithersburg, MD), and the substrate was 5-bromo-4-chloro-3-indolylphosphate p-toluidine salt and nitroblue tetrazolium chloride (BRL). liferation of murine BCL, cells in short-term culture (Fig 1) . In a repeat experiment, the activity of B-cell supernatants on BCL, cells was completely removed by preincubation of the supernatants for 2 hours at 22OC with the monoclonal IL-5 neutralizing antibody, TRFK-513 (Fig 2) .
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Eosinophil colony formation assay. Eosinophil colonies were obtained in bone marrow cultures supplemented with EBV-transformed B-cell conditioned medium in numbers comparable with those obtained in cultures receiving 10 U rhIL-5. Only rare colony forming unit-granulocyte macrophage (CFU-GM) or CFU-M colonies were seen in cultures receiving no supplementation, and these colonies were present in similar numbers in supplemented cultures ( Table 1) .
The DNA probe containing the full-length human IL-5 gene specifically hybridized to a 3.2-kb fragment of RNA in all four EBVtransformed B-cell lines tested (Fig 3) .
Immunoreactive bands were found at a molecular weight of approximately 45 Kd, as has been reported for native human IL-5,I4 in culture supernatants of 3 of 4 EBV-transformed B-cell lines studied (Fig 4) .
Northern analysis for ZL-5 mRNA.
Western analysis for IL-5.
DISCUSSION
The finding that B cells can be induced to produce IL-5 by EBV infection is cause for re-evaluation of the interactions 
